Intech Biopharm Ltd (6461) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.058x

Based on the latest financial reports, Intech Biopharm Ltd (6461) has a cash flow conversion efficiency ratio of -0.058x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-64.39 Million ≈ $-2.03 Million USD) by net assets (NT$1.10 Billion ≈ $34.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Intech Biopharm Ltd to measure how much of total assets are equity-financed.

Intech Biopharm Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Intech Biopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Intech Biopharm Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Intech Biopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intech Biopharm Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
UVAT Technology Co Ltd TWO:3580	-0.038x
Tillys Inc NYSE:TLYS	0.101x
Rockridge Resources Ltd V:ROCK	-0.026x
Novonix Ltd AU:NVX	-0.124x
Dardanel Onentas Gida Sanayi AS IS:DARDL	0.287x
Indorama Synthetics Tbk JK:INDR	0.014x
Imaflex Inc V:IFX	0.039x
United Bancorp Inc NASDAQ:UBCP	0.005x

Annual Cash Flow Conversion Efficiency for Intech Biopharm Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Intech Biopharm Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see 6461 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.10 Billion ≈ $34.69 Million	NT$-361.13 Million ≈ $-11.38 Million	-0.328x	+0.79%
2024-12-31	NT$814.28 Million ≈ $25.65 Million	NT$-269.22 Million ≈ $-8.48 Million	-0.331x	-89.15%
2023-12-31	NT$1.17 Billion ≈ $36.79 Million	NT$-204.13 Million ≈ $-6.43 Million	-0.175x	+5.28%
2022-12-31	NT$1.03 Billion ≈ $32.50 Million	NT$-190.39 Million ≈ $-6.00 Million	-0.185x	-23.05%
2021-12-31	NT$1.34 Billion ≈ $42.14 Million	NT$-200.61 Million ≈ $-6.32 Million	-0.150x	-19.06%
2020-12-31	NT$1.33 Billion ≈ $41.86 Million	NT$-167.38 Million ≈ $-5.27 Million	-0.126x	-4.52%
2019-12-31	NT$1.57 Billion ≈ $49.43 Million	NT$-189.09 Million ≈ $-5.96 Million	-0.121x	+22.84%
2018-12-31	NT$1.49 Billion ≈ $46.88 Million	NT$-232.43 Million ≈ $-7.32 Million	-0.156x	-45.69%
2017-12-31	NT$1.36 Billion ≈ $42.70 Million	NT$-145.29 Million ≈ $-4.58 Million	-0.107x	--

About Intech Biopharm Ltd

TWO:6461 Taiwan Biotechnology

Market Cap

$88.22 Million

NT$2.80 Billion TWD

Market Cap Rank

#19568 Global

#1109 in Taiwan

Share Price

NT$15.70

Change (1 day)

+2.61%

52-Week Range

NT$14.40 - NT$25.05

All Time High

NT$57.64